Veeva Systems Inc
VEEV
View Detailed Chart
276.270USD
-0.160-0.06%
Close 09/15, 16:00（ET）Quotes delayed by 15 min
45.27BMarket Cap
55.90P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.06%
5 Days
-2.30%
1 Month
-1.55%
6 Months
+18.03%
Year to Date
+31.40%
1 Year
+26.76%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-15Key Insights
The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
32
analysts
Buy
Current Rating
312.506
Target Price
+13.05%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 27.45% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 46.43.
Fairly Valued
The company’s latest PE is 57.41, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 156.11M shares, decreasing 0.77% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 14.90M shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.
Ticker SymbolVEEV
CompanyVeeva Systems Inc
CEOMr. Peter P. Gassner
Websitehttps://www.veeva.com/medtech/
Related Instruments
-1.04%
-3.49%
-2.77%
-0.79%
-1.96%
+0.39%
+1.94%
+1.73%
-0.11%
+1.24%
+6.10%
-1.01%
+1.36%
-2.04%
+3.75%
-0.24%
-1.13%
+0.09%
+1.23%
+1.35%
